Ottobock Overview

  • Year Founded
  • 1919

Year Founded

  • Status
  • Public

  • Employees
  • 9,454

Employees

  • Stock Symbol
  • OBCK

Stock Symbol

  • Investments
  • 37

  • Share Price
  • $42.12
  • (As of Tuesday Closing)

Ottobock General Information

Description

Ottobock SE & Co KGaA is a medical technology company. It specializes in healthcare products and solutions designed to improve mobility and quality of life for people with disabilities or limited mobility. The company's portfolio includes prosthetics, orthotics, neuro-orthotics, rehabilitation products, wheelchairs, and bionic exoskeletons. The company manages its business activities through the operating segments EMEA (Europe, Middle East and Africa), Americas (North and South America) and APAC (Asia Pacific). The company develops, produces and distributes medical technology products and components in these regions and operates an extensive network of patient care facilities. The majority of revenue is derived from the EMEA segment.

Contact Information

Formerly Known As
Orthopädische Industrie
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Corporate Office
  • Max-Näder-Strasse 15
  • 37115 Duderstadt
  • Germany
+49 04401
Primary Industry
Therapeutic Devices
Stock Exchange
FRA
Vertical(s)
Corporate Office
  • Max-Näder-Strasse 15
  • 37115 Duderstadt
  • Germany
+49 04401

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ottobock Stock Performance

As of 17-Nov-2026, Ottobock’s stock price is $42.12. Its current market cap is $2.7B with 64M shares.

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$42.12 $43.49 $41.79 - $87.89 $2.7B 64M 518.42 $2.34

Ottobock Financials Summary

As of 30-Jun-2026, Ottobock has a trailing 12-month revenue of $2.02B.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 4,854,115 6,258,599
Revenue 2,021,814 1,894,938 1,736,444 1,617,811
EBITDA 474,541 425,597 317,163 275,388
Net Income 150,015 101,746 32,679 53,022
Total Assets 2,576,763 2,407,499 2,102,476 2,195,877
Total Debt 1,391,150 1,234,642 1,253,681 1,312,441
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Ottobock Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Ottobock‘s full profile, request access.

Request a free trial

Ottobock Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Ottobock SE & Co KGaA is a medical technology company. It specializes in healthcare products and solutions designed to i
Therapeutic Devices
Duderstadt, Germany
9,454 As of 2026

Porta Westfalica, Germany
 

Reykjavik, Iceland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Ottobock Competitors (32)

One of Ottobock’s 32 competitors is Meyra Group, a Private Equity-Backed company based in Porta Westfalica, Germany.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Meyra Group Private Equity-Backed Porta Westfalica, Germany
Embla Medical Corporation Reykjavik, Iceland
Inogen Formerly VC-backed Beverly, MA
Medtronic Corporation Minneapolis, MN
Joerns Healthcare Private Equity-Backed Charlotte, NC
You’re viewing 5 of 32 competitors. Get the full list »

Ottobock Patents

Ottobock Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
DE-102025119751-B3 Orthopedic technical equipment Active 21-May-2025
WO-2026229119-A1 Prosthetic foot, foot cover, prosthetic foot insert and covering for a prosthetic foot, and method for assembling a prosthetic foot Pending 29-Apr-2025
DE-102025116484-A1 Prosthetic foot, foot shell, prosthetic foot insert and cover for a prosthetic foot and method for mounting a prosthetic foot Pending 29-Apr-2025
DE-102025115162-A1 Prosthetic joint Pending 17-Apr-2025
WO-2026219657-A1 Prosthetic joint Pending 17-Apr-2025 A61F2/6607
To view Ottobock’s complete patent history, request access »

Ottobock Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ottobock Investments & Acquisitions (37)

Ottobock’s most recent deal was a Merger/Acquisition with Rehattiva. The deal was made on 01-Oct-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Rehattiva 01-Oct-2026 Merger/Acquisition Specialty Retail
Blue Arbor Technologies 20-Jul-2026 Early Stage VC Therapeutic Devices
Fesia Technology 07-Jul-2026 Merger/Acquisition Therapeutic Devices
Blatchford Norway 13-May-2026 Merger/Acquisition Medical Supplies
Phantom Neuro 21-Nov-2025 Later Stage VC Therapeutic Devices
You’re viewing 5 of 37 investments and acquisitions. Get the full list »

Ottobock ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Healthcare

Industry

Rank

Percentile

Medical Devices

Subindustry

Rank

Percentile

To view Ottobock’s complete esg history, request access »

Ottobock Affiliates

Subsidiaries (26)

Name Industry Location Year Founded
Lindentor 1053. V V Berlin, Germany 2020
Romedis Duderstadt, Germany 2016
Fesia Technology San Sebastian, Spain 2016
Plus Medica OT Dusseldorf, Germany 2015
Otto Bock Healthcare Beteiligungen Duderstadt, Germany 2014
You’re viewing 5 of 26 affiliates. Get the full list.  »

Ottobock FAQs

  • When was Ottobock founded?

    Ottobock was founded in 1919.

  • Where is Ottobock headquartered?

    Ottobock is headquartered in Duderstadt, Germany.

  • What is the size of Ottobock?

    Ottobock has 9,454 total employees.

  • What industry is Ottobock in?

    Ottobock’s primary industry is Therapeutic Devices.

  • Is Ottobock a private or public company?

    Ottobock is a Public company.

  • What is Ottobock’s stock symbol?

    The ticker symbol for Ottobock is OBCK.

  • What is the current stock price of Ottobock?

    As of 17-Nov-2026 the stock price of Ottobock is $42.12.

  • What is the current market cap of Ottobock?

    The current market capitalization of Ottobock is $2.7B.

  • What is Ottobock’s current revenue?

    The trailing twelve month revenue for Ottobock is $2.02B.

  • Who are Ottobock’s competitors?

    Meyra Group, Embla Medical, Inogen, Medtronic, and Joerns Healthcare are some of the 32 competitors of Ottobock.

  • What is Ottobock’s annual earnings per share (EPS)?

    Ottobock’s EPS for 12 months was $2.34.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process